跳至主要内容
临床试验/NCT07194655
NCT07194655尚未招募不适用

Study on the Immediate Analgesic Effect of Yanglingquan Acupoint Treatment for Biliary Colic

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine0 个研究点目标入组 248 人开始时间: 2025年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
248
主要终点
Simplified McGill Pain Questionnaire (SF-MPQ) Score:Visual Analogue Scale (VAS)

研究概览

简要总结

Guided by traditional meridian and acupoint theory, conducting standardized, large-sample, multicenter randomized controlled trials (RCTs) to evaluate the clinical efficacy of pattern differentiation and meridian-based acupoint selection for biliary colic across multiple levels can provide high-quality research evidence for developing evidence-based guidelines or optimal treatment protocols. This holds significant importance for enhancing the clinical efficacy of acupuncture in treating biliary colic and promoting its widespread clinical application. Therefore, this study will conduct a multicenter, large-sample randomized controlled trial comparing the clinical effects of acupuncture at Yanglingquan (GB34) versus drug therapy for acute cholecystitis biliary colic. It aims to investigate the clinical efficacy and safety of acupuncture treatment for acute cholecystitis biliary colic.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Meets diagnostic criteria for cholecystitis according to both Chinese and Western medicine;
  • •Patients exhibiting clinical manifestations of biliary colic with a Visual Analogue Scale (VAS) score >4;
  • •Aged 18 to 65 years;
  • •Patients provide informed consent and voluntarily participate in this study.

排除标准

  • •Patients meeting criteria for emergency surgery;
  • •Patients with psychiatric issues unable to cooperate with treatment;
  • •Patients with severe complications such as suppurative cholecystitis, suppurative cholangitis, acute pancreatitis, gallbladder perforation, tumors, or severe infections;
  • •Patients with other serious comorbidities including liver, brain, kidney, or cardiovascular diseases;
  • •Patients with severe local lesions (e.g., infections, burns, scalds) where acupuncture is contraindicated;
  • •Pregnant women and lactating women;
  • •Patients who have already undergone other treatment modalities.

研究组 & 干预措施

Control group

No Intervention

Drug therapy only

Acupuncture group A

Experimental

Acupuncture at the Yanglingquan point

干预措施: Acupuncture at the Yanglingquan point (Other)

Acupuncture group B

Experimental

Acupuncture at the Xiabai Point

干预措施: Acupuncture at the Xiabai Point (Other)

Acupuncture group C

Sham Comparator

Acupuncture at non-meridian points

干预措施: Acupuncture at non-meridian points (Other)

结局指标

主要结局

Simplified McGill Pain Questionnaire (SF-MPQ) Score:Visual Analogue Scale (VAS)

时间窗: One week from enrollment to the end of treatment

This is a simple, single-dimensional method for measuring pain intensity, which consists of a 10-centimeter horizontal line. The left end is marked with "No pain", and the right end is marked with "most severe pain". The patient marks a point on the line representing the current intensity of their pain.The higher the score, the worse the result.

Simplified McGill Pain Questionnaire (SF-MPQ) Score:Pain Index (PRI)

时间窗: One week from enrollment to the end of treatment

It contains 15 pain description words, which are divided into two categories: sensory items (11 words) : throbbing pain, shooting pain, stabbing pain, sharp pain, spastic pain, biting pain, heat-burning pain, aching pain, heavy pain, touch pain, tearing pain. Emotional items (4 words) : Tiredness - feeling exhausted, nauseating, fear, punishment - feeling tormented. PRI scoring criteria: 0 = None; 1= mild; 2= moderate; 3= Severe. Calculate the total score. The higher the score, the worse the result.

Simplified McGill Pain Questionnaire (SF-MPQ) Score-Current Pain Intensity (PPI)

时间窗: One week from enrollment to the end of treatment

This is a single overall score for the current intensity of pain. It adopts a 5-point scoring method: 0= painless; 1= Mild pain; 2= uncomfortable pain; 3= Distress pain; 4= Terrifying pain; 5= Extreme pain. The higher the score, the worse the result.

Gallstones Traditional Chinese Medicine Syndrome Scoring

时间窗: One week from enrollment to the end of treatment

Referring to the relevant content of the "Clinical Guidelines for New Traditional Chinese Medicine Drugs (Trial)" 2002 edition "Gallstones" chapter, a quantitative scoring table for TCM syndromes was formulated. This study scored three symptoms: right upper abdominal pain, tenderness in the gallbladder area, and nausea and vomiting. The main symptoms (pain type) were scored as 0 points, 3 points, 6 points, and 9 points respectively for asymptomatic, mild symptoms, moderate symptoms, and severe symptoms. For secondary symptoms (nausea and vomiting), scores of 0, 1, 2, and 3 are given based on the above conditions. The minimum value is 0 points and the maximum value is 12 points.The scoring time is before treatment and 12 hours after treatment.The higher the score, the worse the result.

次要结局

  • Biliary tract ultrasound(One week from enrollment to the end of treatment)
  • The levels of plasma C-reactive protein (CRP)(One week from enrollment to the end of treatment)
  • The levels of plasma cholecystokinin (CCK)(One week from enrollment to the end of treatment)
  • The levels of plasma β -endorphin (β-EP)(One week from enrollment to the end of treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jiawen Dong

physiciancertified doctor

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

相似试验